Commonwealth Equity Services’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
DCM
ACA
DTC
OCA
CC
Commonwealth Equity Services's DFTX Position: Q1 2026 in Review
Commonwealth Equity Services reduced its Definium Therapeutics (DFTX) stake by 25% in Q1 2026, selling an estimated $57K and leaving 10,251 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #4020.
Commonwealth Equity Services first reported a position in DFTX in Q2 2021 and has held it in 17 quarters since. The position peaked at $418K in Q2 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.
- Commonwealth Equity Services held 10,251 shares of Definium Therapeutics worth $194K as of Q1 2026.
- Commonwealth Equity Services sold 3,360 Definium Therapeutics shares in Q1 2026, an estimated $57K.
- Definium Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4020 holding.
- Commonwealth Equity Services first reported a position in Definium Therapeutics in Q2 2021 and has held it in 17 quarters since.
- Commonwealth Equity Services's Definium Therapeutics position peaked at $418K in Q2 2021.
- 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.